Security key
75886F107
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 89,209,869
- Total 13F value
- $46,858,212,368
- Share change
- -2,558,432
- Put/Call ratio
- 86%
- SEC-reported price per share
- $525.00
- Number of holders
- 1,192
- Value change
- -$1,426,702,234
- Number of buys
- 564
- Number of sells
- 674
- Shares outstanding
- 103,945,862
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
1,192
Top holders
10
REGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
REGENERON PHARMACEUTICALS, INC. SEC filings
REGENERON PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75886F107
Recent filing periods:
Ownership snapshot
Top reported holders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JPMORGAN CHASE & CO
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
13D/G
Lead comparable stake: 4.4%
13D/G row: JPMORGAN CHASE & CO
Showing 1-6 of 15 holder rows.
Quick read
JPMORGAN CHASE & CO leads the comparable SEC ownership view at 4.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JPMORGAN CHASE & CO's linked filing trail.
Comparable ownership
Top 5
JPMORGAN CHASE & CO
4.4%
FMR LLC
3.2%
VANGUARD GROUP INC
9.1%
BlackRock, Inc.
8.6%
STATE STREET CORP
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
13D/G
Company
|
4.4%
from 13D/G
|
$3,588,599,008
5,658,197 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13F
13D/G
Company
|
3.2%
from 13D/G
|
$4,819,250,174
7,598,584 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
9.1%
|
$5,966,766,709
9,407,891 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
8.6%
|
$5,661,061,035
8,925,880 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
4.6%
|
$3,037,745,428
4,789,659 shares
|
— | 31 Mar 2025 |
| Capital International Investors |
13F
Company
|
3.8%
|
$2,530,196,274
3,989,132 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,192
Shares
89,209,869
Rows available
1,192
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
1,275
Q2 2025 holders
1,192
Holder diff
-83
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend